| Cardiovascular mortality |  | All-cause mortality |  |  | |||
---|---|---|---|---|---|---|---|---|
 | Number | RR (95% CI) | P a | I 2 (%) | Number | RR (95% CI) | P a | I 2 (%) |
Location: | Â | Â | Â | Â | Â | Â | Â | Â |
United States | 2 | 1.04 (0.98 to 1.10) | 0.50 | 0.0 | - | - | - | - |
Europe | 4 | 0.90 (0.73 to 1.12) | 0.20 | 36.1 | 3 | 0.85 (0.68 to 1.06) | 0.08 | 61.1 |
Asia | 3 | 0.95 (0.81 to 1.12) | 0.56 | 0.0 | 2 | 0.80 (0.52 to 1.23) | 0.002 | 89.9 |
Sex: | Â | Â | Â | Â | Â | Â | Â | Â |
Male and female | 3 | 0.99 (0.70 to 1.39) | 0.22 | 33.3 | 2 | 0.66 (0.53 to 0.82) | 0.45 | 0.0 |
Male | 5 | 0.88 (0.74 to 1.06) | 0.06 | 55.2 | 2 | 0.91 (0.74 to 1.11) | 0.14 | 54.7 |
Female | 5 | 1.04 (0.95 to 1.13) | 0.90 | 0.0 | 2 | 0.90 (0.63 to 1.29) | 0.001 | 90.6 |
Follow-up time: | Â | Â | Â | Â | Â | Â | Â | Â |
>10 years | 6 | 1.03 (0.97 to 1.08) | 0.46 | 0.0 | 3 | 0.98 (0.89 to 1.07) | 0.56 | 0.0 |
≤10 years | 3 | 0.87 (0.70 to 1.08) | 0.28 | 21.5 | 2 | 0.71 (0.60 to 0.83) | 0.26 | 22.0 |
Controlling for vitamin D status in models: | Â | Â | Â | Â | Â | Â | ||
Yes | 4 | 0.92 (0.74 to 1.15) | 0.22 | 32.7 | 2 | 0.87 (0.65 to 1.16) | 0.03 | 80.0 |
No | 5 | 1.02 (0.97 to 1.08) | 0.44 | 0.0 | 3 | 0.79 (0.57 to 1.10) | 0.006 | 80.7 |